Phase II Clinical Trial of Celecoxib or (NSAID) in Bladd

Sabichi, Anita L.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Division of Cancer Prevention And Control (NCI)
• Type: Research and Development Contracts (N01)
• Project #: N01CN085186-002
• Application #: 6357844
• Project Start: 1998-09-30
• Project End: 2003-09-29
• Budget Start: 2000-09-30
• Budget End: 2001-09-29
• Fiscal Year: 2000
• Total Cost: $800,984

Institution

• Name: University of Texas MD Anderson Cancer Center
• Department: Internal Medicine/Medicine
• Type: Other Domestic Higher Education
• DUNS #: 001910777
• City: Houston
• State: TX
• Country: United States
• Zip Code: 77030

Publications

Lerner, Seth P; Tangen, Catherine M; Sucharew, Heidi et al. (2009) Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer. Urol Oncol 27:155-9